Methodist Fremont Health Hosts Advanced Lung Cancer Screening Event

0
5

Key Takeaways

  • Methodist Fremont Health showcased Intuitive Surgical’s Thoracic Oncology Mobile Experience, an 18‑wheel, 80,000‑pound unit that brings advanced lung‑cancer screening and biopsy technology to rural Nebraska.
  • Dr. Adam Wells emphasized that rural Nebraskans are dramatically underscreened for lung cancer, contributing to higher mortality rates compared with urban areas.
  • Current state‑wide screening reaches only about 30 % of the eligible population, leaving a substantial gap that the mobile unit aims to close.
  • A Fremont resident, Darrell Hultgren, shared how a routine CT scan uncovered histoplasmosis, prompting rapid follow‑up biopsy and treatment within ten days thanks to the health system’s coordinated navigation.
  • Plans are underway to add the Ion Robotic System to the Fremont campus later this year, further enhancing early‑detection capabilities locally.
  • Wells recommends annual low‑dose CT screening for individuals aged 50‑80 with a smoking history, urging community members to take advantage of available services.

Event Overview and Mobile Unit Description
Methodist Fremont Health hosted a hands‑on demonstration on Monday featuring Intuitive Surgical’s Thoracic Oncology Mobile Experience—a massive, self‑contained 18‑wheel trailer weighing 80,000 pounds. The unit houses the same cutting‑edge equipment used for low‑dose CT scans, navigational bronchoscopy, and biopsy procedures at Methodist’s Omaha and Council Bluffs campuses. By transporting this technology directly to Fremont, the health system aimed to give patients, clinicians, and community members a tangible look at how lung cancer can be detected and sampled in its earliest, most treatable stages. The mobile lab’s presence underscored a strategic push to overcome geographic barriers that often prevent rural residents from accessing high‑tech diagnostic tools.

Rural Access as the Central Motivation
The driving force behind the event was the stark disparity in lung‑cancer screening between urban and rural Nebraska. Dr. Adam Wells, a pulmonary and critical care physician at Methodist, presented data showing that rural Nebraskans are “massively under screened,” which correlates with markedly higher mortality rates from the disease. He explained that early detection through screening can shift the prognosis from a late‑stage, often fatal diagnosis to a curable condition when caught early. By bringing the mobile unit to Fremont, Methodist hopes to shrink that gap, accelerate time‑to‑diagnosis, and ultimately improve survival outcomes for residents who might otherwise travel long distances or forgo screening altogether.

Current Screening Rates and the Size of the Gap
Although Nebraska ranks eighth nationally for lung‑cancer screening among eligible individuals, Wells noted that this figure captures only roughly 30 % of the population that should be screened according to guidelines. In other words, seven out of ten people who meet the age‑and‑smoking‑history criteria are not receiving the low‑dose CT scans that could save their lives. He characterized this as a “huge amount of people we would like to catch sooner,” acknowledging that while the state and urban centers are performing relatively well, rural communities lag far behind. The mobile experience is therefore positioned as a concrete step toward raising that screening proportion and reducing preventable deaths.

A Patient’s Story: From Incidental Finding to Timely Care
Fremont resident Darrell Hultgren provided a vivid illustration of how the system’s coordination can work in practice. In February, a CT scan performed for unrelated reasons revealed histoplasmosis—a fungal infection caused by inhaling spores from contaminated soil. Initial imaging showed only four or five lesions, but a follow‑up scan a short time later displayed 25 active fungal growths, raising concern that the process might be malignant. Because the abnormality was flagged promptly, Methodist’s nurse navigator intervened, arranging a biopsy at the Omaha location within ten days. Hultgren confirmed that the lesion was ultimately benign, and he is now completing the final month of antifungal therapy, with a follow‑up scan planned to verify resolution. His experience highlights the value of incidental findings, rapid navigation, and seamless referral pathways.

The Role of the Nurse Navigator and Care Coordination
Wells emphasized that the speed with which Hultgren moved from imaging to biopsy was largely due to the health system’s nurse navigator program. Navigators act as liaisons who track abnormal results, educate patients about next steps, schedule appointments, and eliminate logistical hurdles such as transportation or insurance paperwork. In rural settings where patients may lack familiarity with specialist services or face travel constraints, navigators can be the difference between a delayed diagnosis and timely intervention. The mobile unit’s visit also served to raise awareness of this support resource among community members who might not otherwise know it exists.

Future Plans: Introducing the Ion Robotic System to Fremont
Looking ahead, Dr. Wells revealed that Methodist aims to station the Ion Robotic System—an advanced platform for percutaneous lung‑lesion biopsy—on the Fremont campus sometime this year. The Ion system enables physicians to reach peripheral nodules with unprecedented precision using a flexible, catheter‑based approach, thereby reducing complications and increasing diagnostic yield. By integrating this technology locally, Fremont patients would gain access to a minimally invasive biopsy option without needing to travel to Omaha or Council Bluffs. Wells expressed optimism that the combination of mobile screening, robotic biopsy, and robust navigation will create a comprehensive early‑detection pipeline tailored to the needs of rural Nebraskans.

Screening Recommendations for At‑Risk Individuals
Wells concluded with a clear public‑health message: individuals aged 50 to 80 who have a history of smoking should undergo annual low‑dose CT screening for lung cancer, regardless of whether they exhibit symptoms. He stressed that screening is most effective when performed before any clinical signs appear, as it can detect cancers at a stage where surgical resection or targeted therapies offer a high chance of cure. Community outreach, educational events like the mobile experience, and easy access to screening sites are all vital components of boosting participation rates. He urged residents to discuss their eligibility with primary‑care providers and to take advantage of the services Methodist is expanding across the region.

Conclusion: Bridging the Urban‑Rural Divide in Lung Cancer Care
The Methodist Fremont Health event illustrated a multifaceted approach to addressing lung‑cancer disparities: delivering state‑of‑the‑art diagnostic technology directly to underserved areas, leveraging nurse navigators to streamline care, and planning to bring advanced robotic biopsy tools to the local campus. By highlighting both the systemic gaps and the tangible steps being taken to close them, the initiative serves as a model for how health systems can improve equity in cancer prevention and treatment. Continued investment in mobile units, workforce training, and community engagement will be essential to ensure that all Nebraskans—regardless of zip code—benefit from early detection and the improved survival it brings.

SignUpSignUp form

LEAVE A REPLY

Please enter your comment!
Please enter your name here